Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseBone MarrowBone Marrow TransplantationTransplantation ConditioningHematologic NeoplasmsBone Marrow CellsCytomegalovirus InfectionsTransplantation, AutologousRoseolovirus InfectionsStem CellsAspergillosisHistocompatibility TestingHematopoietic Stem CellsTreatment OutcomeCytomegalovirusFetal BloodBone and BonesRetrospective StudiesTransplantation ChimeraTissue DonorsPeripheral Blood Stem Cell TransplantationGraft SurvivalBusulfanRecurrenceLeukemiaGraft vs Leukemia EffectWhole-Body IrradiationRemission InductionImmunosuppressive AgentsHistocompatibilityLeukemia, Myeloid, AcuteMyeloablative AgonistsMultiple MyelomaGraft vs Tumor EffectVidarabineTime FactorsAntigens, CD34Immunocompromised HostLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesCell DifferentiationTransplantationAnemia, AplasticCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionHematopoietic Stem Cell MobilizationCells, CulturedMyelodysplastic SyndromesSurvival AnalysisSalvage TherapyOpportunistic InfectionsEmbryonic Stem CellsFlow CytometrySpinal CordSurvival RateAdult Stem CellsHematologic DiseasesAcute DiseaseMice, Inbred C57BLBone Marrow DiseasesVirus ActivationMycosesSiblingsBone Marrow PurgingHepatic Veno-Occlusive DiseaseCyclophosphamideHematopoiesisBone RemodelingChimerismBone Marrow ExaminationImmunosuppressionGraft RejectionLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsCell SeparationMinor Histocompatibility AntigensHLA AntigensDisease-Free SurvivalLeukemia, MyeloidGranulocyte Colony-Stimulating FactorNeoplasm, ResidualLeukocyte TransfusionFollow-Up StudiesAntilymphocyte SerumBone Marrow NeoplasmsMesenchymal Stromal CellsHerpesvirus 6, HumanMelphalanMesenchymal Stem Cell TransplantationGanciclovirFatal OutcomePluripotent Stem CellsImmunophenotypingBlood Transfusion, AutologousTransplantation Immunology